Search Results

The RapidBlue™ System is a thermal regulating system intended to induce, maintain and reverse mild hypothermia in neurosurgical patients in surgery and in recovery/intensive care, to achieve and/or maintain normothermia in cardiac surgery patients in surgery and in recovery/ intensive care, and for use in fever reduction, as an adjunct to other antipyretic therapy, in patients with cerebral infarction and intracerebral hemorrhage who required access to the central venous circulation and who are intubated and sedated.

The subject device is a thermal regulating system consisting of three (3) parts:

• 1. A console containing refrigeration/heating elements, a heat exchanger to cool and warm the circulating fluid, a pump to circulate that fluid, and controls and software necessary to operate the system.
• 2. A sterile cassette to connect the console to the catheter, and through which the heat transfer fluid is circulated to and from the catheter in a closed-loop manner.
• 3. An endovascular catheter having a heat exchange element at the distal end, through which a thermal transfer fluid is circulated to cool or warm the blood, and which is available in various diameters from 10.7 french to 14 french.
     The modified system offers a mode, which uses conventional, off-the-shelf temperature probes such as YSI-400 esophageal probes, to monitor patient temperature and control system operation, and one mode that uses an integrated temperature sensor in the catheter.

The provided text is a 510(k) summary for the RapidBlue™ System, a thermal regulating system. It describes the device, its intended use, and its comparison to predicate devices. However, this document does not contain explicit acceptance criteria or a study detailing device performance against such criteria.

The 510(k) summary is a premarket notification to demonstrate substantial equivalence to a legally marketed predicate device, rather than a detailed report of a new clinical trial proving specific performance metrics with acceptance criteria.

Therefore, the requested information cannot be extracted from the provided text for the following reasons:

1. A table of acceptance criteria and the reported device performance: This information is not present. The document states that the device "has equivalent performance in inducing and reversing hypothermia, and in maintaining normothermia, as do other thermal regulating systems commercially available in the U.S." but does not provide specific metrics or acceptance thresholds.
2. Sample size used for the test set and the data provenance: No test set is described or analyzed in this document.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable, as there's no described test set requiring ground truth establishment by experts.
4. Adjudication method for the test set: Not applicable.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, and the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. The device is a physical thermal regulating system, not an AI-assisted diagnostic or therapeutic tool for human readers.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable.
7. The type of ground truth used: Not applicable.
8. The sample size for the training set: Not applicable.
9. How the ground truth for the training set was established: Not applicable.

In summary, the provided document focuses on demonstrating substantial equivalence based on indications for use, design characteristics, biocompatible materials, and general performance equivalence to existing predicate devices, rather than presenting a performance study with specific acceptance criteria and detailed study parameters.

Ask a specific question about this device

The Celsius Control™ System is a thermal regulating system intended to induce, maintain and reverse mild hypothermia in neurosurgical patients in surgery and in recovery/intensive care, to achieve and/or maintain normothermia in cardiac surgery patients in surgery and in recovery/ intensive care, and for use in fever reduction, as an adjunct to other antipyretic therapy, in patients with cerebral infarction and intracerebral hemorrhage who required access to the central venous circulation and who are intubated and sedated.

The subject device is a thermal regulating system consisting of three (3) parts:

• an endovascular catheter having a heat exchange element at the distal end, through which a thermal transfer fluid is circulated to cool or warm the blood, and which is available in various diameters from 9 french to 14 french;
• a console containing refrigeration/heating elements, a heat exchanger to cool and warm the circulating fluid, a pump to circulate that fluid, and controls and software necessary to operate the system; and
• a sterile tubing set to connect the console to the catheter, and through which the thermal transfer fluid is circulated.

Two (2) models of the System are available: One which uses conventional, off-the-shelf thermistor probes such as YSI-400 esophageal probes, to monitor patient temperature and control System operation, and one that uses a thermistor integral to the catheter.

The provided text is a 510(k) Summary for the INNERCOOL therapies, Inc. Celsius Control™ System. It describes the device, its intended use, and comparison to predicate devices, but it does not contain information about specific acceptance criteria, device performance testing results, sample sizes for test or training sets, ground truth establishment, expert qualifications, or MRMC studies. Therefore, I am unable to fill out the requested table and answer the questions based solely on the provided text.

The document focuses on establishing substantial equivalence to predicate devices for regulatory clearance, rather than detailing the specifics of performance studies against defined acceptance criteria.

Information NOT Found in the Document:

1. A table of acceptance criteria and the reported device performance: Not present. The document states "The subject device has equivalent performance in inducing and reversing hypothermia, and in maintaining normothermia," but it doesn't provide specific quantitative acceptance criteria or reported performance metrics.
2. Sample sized used for the test set and the data provenance: Not present.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not present.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not present.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not present. This device is a thermal regulating system, not an AI-assisted diagnostic tool for human readers.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done: Not present. This device is a physical therapeutic system, not an algorithm.
7. The type of ground truth used (expert concensus, pathology, outcomes data, etc): Not applicable in the context of this device's type of evaluation as described. Performance for a thermal regulating system would typically involve physiological measurements in subjects or bench testing.
8. The sample size for the training set: Not present.
9. How the ground truth for the training set was established: Not present.

Ask a specific question about this device